Maternal use of selective serotonin-reuptake inhibitors, however, has been associated with persistent pulmonary hypertension of the newborn.

More information: Jonas Windrich et al, RAS-MAPK Pathway Mutations in Congenital Pulmonary Airway Malformations, American ...